戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 m of the drug, Cremophor EL (polyethoxylated castor oil).
2 ohol) (PVA) and polyoxyethylene hydrogenated castor oil.
3  RT are produced annually as a by-product of castor oil.
4 t it mediates the pharmacological effects of castor oil.
5 d for paclitaxel containing polyoxyethylated castor oil.
6  with paclitaxel containing polyoxyethylated castor oil.
7 ity control of cooking oils adulterated with castor oil.
8 astor oil was noticed and compared to virgin castor oil.
9  transit time or time to diarrhea induced by castor oil.
10 bre, waste low density polyethene (LDPE) and castor oil alkyd resin was fabricated.
11  nonprotein constituents in the seed are the castor oil and carbohydrates.
12 sm underlying the pharmacological effects of castor oil and indicate a role of the EP(3) receptor as
13 nc, cobalt and barium were incorporated with castor oil and subsequently structures were established
14 thesized from an alkenoic ester derived from castor oil and then polymerized with varied monomers, in
15 ly(lactic acid) (PLA), bio-based plasticiser castor oil, and solvent-free thermal mixing.
16                               The effects of castor oil are mediated by ricinoleic acid, a hydroxylat
17  human consumption and recently FDA approved castor oil as over-the-counter (OTC) for laxative drug.
18 eter, composed of biocompatible surfactants, castor oil as plasticizers, and ion exchangers.
19 of solvents, was compared with polyethylated castor oil-based standard paclitaxel in patients with me
20 cid, a hydroxylated fatty acid released from castor oil by intestinal lipases.
21                                              Castor oil (COL) is a vegetable oil and naturally polyol
22                            Syntheses of four castor oil fatty acid-based novel lipoconjugates of phen
23 stered by using 4% CsA eye drops or vehicle (castor oil) four times daily for 10 days.
24               Despite the wide-spread use of castor oil in conventional and folk medicine, the molecu
25  with paclitaxel containing polyoxyethylated castor oil in the formulation.
26       Each compound was assessed in a rodent castor oil-induced diarrhea model for its ability to red
27 n intestinal epithelial cells did not affect castor oil-induced diarrhea, mice lacking EP(3) receptor
28 ation (FDA) permitted for direct addition of castor oil into food for human consumption and recently
29                                              Castor oil is one of the oldest drugs.
30                                    Thus, the castor oil metabolite ricinoleic acid activates intestin
31 ribes the effects of hydroxylated biodiesel (castor oil methyl ester - COME) on the properties, combu
32 ttributable to drug formulation (polyoxyl 35 castor oil or hyperosmolarity of the SU5416 preparation)
33                      Ricin produced from the castor oil plant, Ricinus communis, is a well-known toxi
34 ith recycled PLA, carbon black and bio-based castor oil plasticiser, offering a sustainable platform
35                                In developing castor oil seeds (Ricinus communis) a novel, allosterica
36 explanation for its accumulation to ~0.7% in castor oil, the biosynthetic origin of which had remaine
37 CB) alongside recycled poly(lactic acid) and castor oil to create an electrically conductive additive
38 2DEHSPM completely prevented diarrhea in the castor oil-treated rat model at a dose of 5 mg/kg, just
39 rimarily of economic interest as a source of castor oil, used for the production of high-quality lubr
40 anced antioxidant nature of metal containing castor oil was noticed and compared to virgin castor oil
41     Ricinoleic acid (the active principle of castor oil) was the more potent, producing fluid secreti
42                           Metoclopramide and castor oil were most strongly associated with an increas
43 ing this concept, nature-guided estolides of castor oil were synthesized.